Resistance of SARS-CoV-2 beta and gamma variants to plasma collected from Canadian blood donors during the spring of 2020.

Steven J DrewsKento T AbeQueenie HuReuben SamsonAnne-Claude GingrasKaren ColwillBhavisha RathodJenny WangMahya Fazel-ZarandiQi-Long YiAlyssia RobinsonHeidi WoodAshleigh TuiteDavid FismanDavid H EvansYi-Chan J LinSheila F O'Brien

Published in: Transfusion (2021)

This preliminary data can be used as a justification for limiting the use of first wave plasma products in upcoming clinical trials but cannot be used to speculate on general trends in the immunity of Canadian blood donors to SARS-CoV-2.

Keyphrases

sars cov
clinical trial
respiratory syndrome coronavirus
electronic health record
copy number
big data
machine learning
deep learning
double blind